Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.38 |
| ▸ | CCKBR | P32239 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tenidap SCHEMBL3751878 | 1.00 | MEN1 (0.42) | MEN1KMT2AHTTCYP1A2CYP2C9 | |
| Tenidap SCHEMBL24922 | 1.00 | MEN1 (0.42) | MEN1KMT2AHTTCYP1A2CYP2C9 | |
| Tenidap SCHEMBL30597938 | 0.86 | KMT2A (0.41) | MEN1KMT2AHTTCYP1A2CYP2C9 | |
| Tenidap SCHEMBL43098 | 0.86 | KMT2A (0.41) | MEN1KMT2AHTTCYP1A2CYP2C9 | |
| Tenidap SCHEMBL9216494 | 0.85 | ALDH1A1 (0.33) | HTTNPSR1ALDH1A1HSP90AA1 | |
| SCHEMBL9215467 | 0.84 | ALDH1A1 (0.36) | MEN1KMT2AHTTCYP1A2CYP2C9 | |
| SCHEMBL8816115 | 0.84 | CHEK1 (0.41) | KMT2AKDM4EALDH1A1RXFP1 | |
| SCHEMBL8816112 | 0.84 | CHEK1 (0.41) | KMT2AKDM4EALDH1A1RXFP1 | |
| SCHEMBL3676246 | 0.83 | ALDH1A1 (0.33) | HTTNPSR1ALDH1A1HSP90AA1 | |
| Ilonidap SCHEMBL42518 | 0.83 | ALDH1A1 (0.35) | MEN1KMT2AHTTCYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7132441-B2 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor | G.D. SEARLE & CO. (US) | 2006-11-07 | — | — | US | claimed |
| US-20230293594-A1 | METHODS OF TREATING NEUROPSYCHIATRIC DISORDERS | UNIV ROCHESTER (US) | 2023-09-21 | — | — | US | disclosed |
| US-11690876-B2 | Methods of treating neuropsychiatric disorders | UNIVERSITY OF ROCHESTER (US) | 2023-07-04 | — | — | US | disclosed |
| US-20200197445-A1 | METHODS OF TREATING NEUROPSYCHIATRIC DISORDERS | UNIVERSITY OF ROCHESTER | 2020-06-25 | — | — | US | disclosed |
| CN-110913689-A | Methods of treating neuropsychiatric disorders | 罗切斯特大学 | 2020-03-24 | — | — | CN | disclosed |
| EP-3621434-A2 | METHODS OF TREATING NEUROPSYCHIATRIC DISORDERS | University of Rochester (US) | 2020-03-18 | — | — | EP | disclosed |
| WO-2018209022-A2 | METHODS OF TREATING NEUROPSYCHIATRIC DISORDERS | UNIVERSITY OF ROCHESTER (US) | 2018-11-15 | — | — | WO | disclosed |
| US-20170112860-A1 | NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHODS FOR TREATING BRAIN SWELLING | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-04-27 | — | — | US | disclosed |
| US-20150272964-A1 | NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHODS FOR TREATING BRAIN SWELLING | U.S. OF AMERICA AS REPRESENTED BY THE DEPT OF VETERANS AFFAIRS | 2015-10-01 | — | — | US | disclosed |
| WO-2015097667-A2 | A COMPOSITION, PROCESS OF PREPARATION OF SAID COMPOSITION, KIT AND A METHOD OF TREATING CANCER | CELLWORKS GROUP, INC., (US) | 2015-07-02 | — | — | WO | disclosed |
| US-20060276411-A1 | Novel non-selective cation channel in neuronal cells and methods for treating brain swelling | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2006-12-07 | — | — | US | disclosed |
| US-7132441-B2 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor | G.D. SEARLE & CO. (US) | 2006-11-07 | — | — | US | disclosed |
| EP-0827399-A1 | INHIBITING PHOTODECOMPOSITION OF 3-SUBSTITUTED-2-OXINDOLES | PFIZER INC. (US) | 1998-03-11 | — | — | EP | disclosed |
| EP-0681580-B1 | PRODRUGS OF ANTIINFLAMMATORY 3-ACYL-2-OXINDOLE-1-CARBOXAMIDES | PFIZER (US) | 1997-07-09 | — | — | EP | disclosed |
| WO-1997013767-A1 | HETEROCYCLICALLY-SUBSTITUTED 1-INDOLE CARBOXAMIDES AS CYCLO-OXYGENASE-2 INHIBITORS | CHEMISCH PHARMAZEUTISCHE FORSCHUNGSGESELLSCHAFT MBH (AT) | 1997-04-17 | — | — | WO | disclosed |
| WO-1996033701-A1 | INHIBITING PHOTODECOMPOSITION OF 3-SUBSTITUTED-2-OXINDOLES | PFIZER INC. (US) | 1996-10-31 | — | — | WO | disclosed |
| EP-0421749-B1 | 3-Aroyl-2-oxindole-1-carboxamides | PFIZER (US) | 1995-12-13 | — | — | EP | disclosed |
| US-5270331-A | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides | PFIZER, INC. (US) | 1993-12-14 | — | — | US | disclosed |
| WO-1993002692-A1 | METHOD OF COMBATTING HIV INFECTIONS | DUKE UNIVERSITY (US) | 1993-02-18 | — | — | WO | disclosed |
| US-5059693-A | REDUCTIVE DEHALOGENATION | PFIZER INC. (US) | 1991-10-22 | — | — | US | disclosed |